Clinical trial · Interventional
Acceptability of Less Harmful Alternatives to Cigarettes
International Study of the Acceptability of Less Harmful Alternatives to Cigarettes (ISALHAC) - A Pilot Study
NCT00957424CI-TRIAL-00025837completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: A study that evaluates participants' beliefs about smokeless tobacco products and nicotine replacement therapy may be useful in helping smokers stop smoking. PURPOSE: This clinical trial is studying the acceptability of less harmful alternatives to cigarettes.
Conditions
Conditions (11)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
| Esophageal Cancer | Malignant Esophageal Neoplasm | CURATED_EXACT | 0.92 |
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
| Kidney Cancer | Malignant Kidney Neoplasm | CURATED_EXACT | 0.92 |
| Leukemia | Leukemia | ONTOLOGY_EXACT | 0.90 |
| Liver Cancer | Malignant Liver Neoplasm | CURATED_EXACT | 0.92 |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Pancreatic Cancer |
Interventions
Interventions (5)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| informational intervention | Other | — | UNRESOLVED |
| internet-based intervention | Other | — | UNRESOLVED |
| nicotine replacement therapy | Drug | — | UNRESOLVED |
| questionnaire administration | Other | — | UNRESOLVED |
| telephone-based intervention | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Overall
- description
- Single-armed study
- interventionNames
- Behavioral: telephone-based intervention
- Drug: nicotine replacement therapy
- Other: informational intervention
- Other: internet-based intervention
- Other: questionnaire administration
Primary outcomes (4)
- measure
- Number of Participants With no Interest in Trial of Harm-reduction Products (HRPs)
- timeFrame
- Baseline
- measure
- Number of Participants Willing to Try HRPs
- timeFrame
- Baseline
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 120 Years
Show eligibility criteria text
DISEASE CHARACTERISTICS: * Currently smokes ≥ 10 cigarettes per day * Not planning to quit smoking in the next 30 days and has not tried to quit in the past 30 days * Medically eligible to receive nicotine-replacement products, based on the NYS Smokers Quitline eligibility criteria PATIENT CHARACTERISTICS: * Not pregnant or nursing * Able to read and speak English * In good general health * No history of heart attack or stroke in the past 2 weeks * No history of chest pains in the past month * No report of physician-diagnosed arrhythmia/irregular heartbeat or use of pacemaker * No report of physician-diagnosed heart disease/coronary artery disease, uncontrolled hypertension, stomach ulcer, diabetes, depression, or asthma PRIOR CONCURRENT THERAPY: * No other concurrent tobacco products or nicotine medications * No concurrent Zyban, Bupropion, Wellbutrin, Chantix, or other smoking cessation medication
References
Publications (0)
Data not yet available
No reference posted for this study.